Skip to main content

Table 4 Measurement of adherence to DTG-based ART by self-report

From: Efficacy, safety, and tolerability of dolutegravir-based ART regimen in Durban, South Africa: a cohort study

Variable

Frequency

Proportion (%)

Pearson chi-squared test

(p)

Missed clinic appointments

  

-

Yes

No

69

392

15.0

85.0

 

Forgotten doses

  

> 0.05

None

Between 1 − 5 times

Between 6 − 10 times

> 10 times

367

88

4

2

79.6

19.1

0.9

0.4

 

ART sharing

  

> 0.05

Yes

No

9

452

2.0

98.0

 

ART borrowing

  

< 0.001

Yes

No

10

451

2.2

97.8

Â